Ingalls & Snyder »

Astrazeneca Plc Ord shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Astrazeneca Plc Ord (AZN) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Astrazeneca Plc Ord

Tip: Access up to 7 years of quarterly data

All positions including Astrazeneca Plc Ord held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astrazeneca Plc Ord by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.8M 30k 197.23

More positions owned by Ingalls & Snyder

Corcept Therapeutics Call Call Option (CORT)
Exxon Mobil Corporation (XOM)
Canadian Nat Res Ltd Med Ter Call Call Option (CNQ)
Williams Companies (WMB)
Pan American Silver Corp Can (PAAS)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
NVIDIA Corporation (NVDA)
Omeros Corporation (OMER)
Deere & Company (DE)

View all positions for Ingalls & Snyder

Top funds holding Astrazeneca Plc Ord

Investor AB
Vanguard Capital Management
Capital Research and Management Company - Division 3
Capital World Investors
Legal & General Group
Bank of America Corporation
Vanguard Asset Management
PRIMECAP Management Company
Franklin Resources
Amundi
Vanguard Fiduciary Trust
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Deutsche Bank Aktiengesellschaft
Henderson Group
Aviva

View all funds holding Astrazeneca Plc Ord